论文部分内容阅读
目的:观察前列地尔治疗高脂血症性胰腺炎的临床疗效。方法:将60例高脂血症性胰腺炎患者随机分为对照组(30例),治疗组(30例)。对照组给予常规治疗,治疗组在对照组治疗基础上给予前列地尔20μg,静脉滴注,1次/d,10 d为1个疗程。比较2组疗效。结果:治疗组总有效率优于对照组(P<0.05),并发症发生率低于对照组(P<0.05)。结论:前列地尔治疗高脂血症性胰腺炎安全、有效。
Objective: To observe the clinical efficacy of alprostadil in the treatment of hyperlipidemic pancreatitis. Methods: 60 cases of hyperlipidemic pancreatitis were randomly divided into control group (30 cases) and treatment group (30 cases). The control group was given routine treatment. The treatment group was given alprostadil 20μg on the basis of the control group. The treatment group received intravenous infusion once a day for 10 days as a course of treatment. Compare 2 groups curative effect. Results: The total effective rate in the treatment group was better than that in the control group (P <0.05), and the complication rate was lower than that in the control group (P <0.05). Conclusion: Alprostadil is safe and effective in the treatment of hyperlipidemic pancreatitis.